Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology

Type:

Video

Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.

May 9, 2011 Mark Herzog, Executive Director of Virginia Biotechnology Association (VABIO)	May 6, 2011 Scientific American’s Worldview 2011 Preview	April 27, 2011 A Conversation with the Michael J. Fox Foundation for Parkinson's Research	April 11, 2011 Brent Ahrens on venture capital funding for biotech companies
April 8, 2011 John Sterling, editor-in-chief of Genetic Engineering and Biotechnology News (GEN)	April 7, 2011 Countdown to Partnering With John Carroll from Fierce Biotech	March 29, 2011 Derek Gregg, Chair of BioWV and Chief Executive Officer of Vandalia Research	March 4, 2011 Dr. Lisa Beth Ferstenberg, Founding CEO of Cellective Therapeutics and a serial entrepreneur